-
Podcast Episode 10 Setting a vision: how an impact-driven pharmaceutical company prioritizes sustainability (Part 1)
In this episode of “10 Billion Reasons”, Krizia Karry sits down with Bailey Risteen, BASF Pharma Solutions Global Sustainability Manager, and Tony Sorenson, Founder and Impact Ambassador of 75Pharma, to discuss what it means to be impact-driven pharmaceutical company, how environmental sustainability fits into the corporate strategy, and what the value chain can do to support that strategy.
Topics:- sustainability
-
Podcast Episode 9 Influence of excipients on dermal drug delivery
In this episode of “10 Billion Reasons”, Gloria Ho and Norman Richardson discuss the role of excipients in dermal drug delivery.
Topics:- topicals
- creams
- ointments
- lipid-based excipients
- skin penetration enhancers
- lotions
- emulsions
- gels
- transdermal patches
- semisolids
-
Podcast Episode 8 The Landscape of Amorphous Solid Dispersions
In this episode of “10 Billion Reasons”, BASF Global Technical Marketing Manager for Solubilization, Dr. Lindsay Johnson, and BASF Senior Manager of South Asia Technical Services and Application Lab, Dr. Rajkiran Narkhede, discuss the landscape of amorphous solid dispersions.
Topics:- solubilization
- Amorphous solid dispersions
- Spray drying
- Hot melt extrusion
- Fluid bed granulation
- Copovidone
- Povidones
- Soluplus
-
Podcast Episode 7 Continuous manufacturing in pharma: advantages and challenges
In this episode of “10 Billion Reasons”, Joao Assis and Krizia Karry brainstormed about the advantage of implementing continuous manufacturing in the pharmaceutical industry, covering the economic aspects, product attributes, quality assurance and process control.
Topics:- orals
- continous manufacturing
- direct compression
-
Podcast Episode 6 Simplifying topical formulation development with co-processed excipients
In this episode of “10 Billion Reasons”, Gloria Ho and Norman Richardson discuss the benefits of using co-processed excipients for topical formulation development.
Topics:- topicals
- co-processed excipients
- emulsions
- creams
-
Podcast Episode 5 Fishing for answers in a sea of complexity: sustainable fish oil sourcing
In this episode of “10 Billion Reasons”, Bailey Risteen, BASF Pharma Solutions Global Sustainability Manager, sits down with Manfred Haag and Douglas Pereira Souza on the procurement team to discuss challenges and best practices in sourcing fish oil and how BASF is taking action.
Topics:- sustainability
- manufacturing
- sourcing
-
Podcast Episode 4 Streamline the tableting process with a co-processed excipient
In this episode of “10 Billion Reasons”, our hosts, Joao Assis and Ashish Joshi discuss the benefits of using co-processed excipients and the significant advantages they can provide to the pharmaceutical industry.
Topics:- orals
- co-processed excipients
- direct compression
- tablets formulation
- pills formulation
- oral dosage forms
-
Podcast Episode 3 What is new: Trends in Biopharma
In this episode of “10 Billion Reasons”, Phil Butler Technical Manager and Nadya Morales-Cummings, Global Tech Marketing Manager for Biopharma Ingredients, tackle new and emerging topics in the biopharma market.
Topics:- biopharma
- cell and gene therapy
- mrna
-
Podcast Episode 2 Is there a “Green” Pill? Sustainability in the Pharmaceutical Industry
In this episode of “10 Billion Reasons”, Bailey Risteen, BASF Pharma Solutions Global Sustainability Manager, explains some of the challenges and opportunities in creating a more sustainable pharmaceutical industry and the progress already being made.
Topics:- sustainability
-
Podcast Episode 1 Fill Me In: Softgels and their Evolution
Softgels have expanded in both their capabilities and their adoption, with contributing recent advancements in quality control understanding, shell alternatives, and innovative approaches to drug loading. In this episode of “10 BillionReasons”, BASF Global Technical Marketing Manager for Solubilization, Lindsay Johnson, explains the value of softgel capsules.
Topics:- Softgels
- PEGs
- soft gelatin ca
- polyethylene glycol
- vegan soft gels
- vegetarian soft gels
Podcasts
Humanity is growing rapidly. On average, we add 250 humans to the world’s population every minute. By 2050 we expect to have added another 2.5 billion people, reaching a world population of 10 billion.
We know the challenges this entails for us and for our planet. More and more people must share the same vital resources such as food, water and energy.
At BASF, these are the 10 Billion Reasons we do what we do every day.
Our mission in BASF Pharma Solutions is to inspire medicines for better lives. Join our Pharma Solutions experts as they explore the innovations and initiatives that are helping our customers worldwide meet current needs while preparing for the future.